$47.98
1.10%
NYSE, Jul 03, 10:59 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$47.98
-6.75 12.33% 1M
+21.35 80.17% 6M
+23.80 98.43% YTD
+27.49 134.16% 1Y
+43.19 901.67% 3Y
+37.61 362.68% 5Y
+38.18 389.59% 10Y
+38.18 389.59% 20Y
NYSE, Closing price Thu, Jul 03 2025
+0.52 1.10%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Basic
Market capitalization
$10.7b
Enterprise Value
$10.4b
Net debt
positive
Cash
$322.7m
Shares outstanding
223.6m
Valuation (TTM | estimate)
P/E
72.7 | 70.1
P/S
6.0 | 4.5
EV/Sales
5.8 | 4.3
EV/FCF
44.0
P/B
19.5
Financial Health
Equity Ratio
67.4%
Return on Equity
26.4%
ROCE
18.9%
ROIC
47.0%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.8b | $2.4b
EBITDA
$137.9m | $330.4m
EBIT
$115.6m | $193.7m
Net Income
$164.4m | $153.1m
Free Cash Flow
$236.5m
Growth (TTM | estimate)
Revenue
86.0% | 62.4%
EBITDA
2,697.8% | 288.3%
EBIT
2,214.4%
Net Income
7,095.7% | 21.4%
Free Cash Flow
355.7%
Margin (TTM | estimate)
Gross
77.0%
EBITDA
7.7% | 13.8%
EBIT
6.5%
Net
9.2% | 6.4%
Free Cash Flow
13.3%
More
EPS
$0.7
FCF per Share
$1.1
Short interest
34.2%
Employees
1k
Rev per Employee
$1.4m
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

9x Buy
45%
9x Hold
45%
2x Sell
10%

Analyst Opinions

20 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Hims & Hers Health Inc.

Assets
Mar '25
447 447
Cash 323 323
Claims 6.94 6.94
Inventories 76 76
Other current assets Other current assets Current assets 41 41
445 445
Property, plant and equipment 218 218
Financial assets - -
Intangible Assets 161 161
Other fixed assets Other assets Fixed assets 183 183
Total Assets 892 892
Liabilities
Mar '25
Equity 549 549
342 342
Current liabilities 280 280
Non-current liabilities 62 62
Total Capital 892 892

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
PRNewsWire
2 days ago
BENSALEM, Pa. , July 3, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Neutral
PRNewsWire
3 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims  between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 131...
Neutral
MarketBeat
3 days ago
There is always a challenging moment in every investor's favorite stock and portfolio, especially when said businesses are still going through what's known as a “growth spurt,” in which lots of things can go extremely well, but also unexpectedly wrong.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today